Indeed, we found that PRMT type I inhibition with MS023 and PRMT1-specific inhibition with TC-E5003 severely impaired growth of Apc-deficient tumor organoids but not normal organoids (Figures 6G,H). Here, PRMT1 is linked to neoplasm.